Oseltamivir

This classification denotes an antiviral agent with the molecular formula C16H28N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 20O93L6F9H, chemically known as 1-cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3r,4r,5s)- but generally known as oseltamivir, which bears US NIH Compound Identifier 65028. European Medicines Agency schedules Oseltamivir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03553MIG. The term OSELTAMIVIR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). World Health Organization schedules oseltamivir in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule oseltamivir under HS 29242995 and SITC 51479. As of Q4 2014, OSELTAMIVIR remains the US FDA Preferred Term for this commodity. Oseltamivir bears US NLM identifiers UMLS ID C0874161 and NCI Concept Code C62061. SMILES: O(C1C(NC(=O)C)C(N)CC(=C1)C(=O)OCC)C(CC)CC.